Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Molecular Cancer Therapeutics|April 18, 2014
Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft modelTerry H Landowski, Jaime Gard, Erika Pond, et al.
Mabs|November 7, 2025
Paratope plasticity determines anti-HER2 (4B5) antibody specificityP Daniel Warren, Terry H Landowski, Mark S Dodson, et al.
Cancer Biology & Therapy|December 9, 2014
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitorsBetty K Samulitis, Kelvin W Pond, Erika Pond, et al.
Investigational New Drugs|November 27, 2012
Characterization of a membrane-active anti-tumor agent, UA8967Robert T Dorr, Betty K Samulitis, Lee Wisner, et al.
American Journal of Cancer Research|October 12, 2020
A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancerDavendra Sohal, Smitha Krishnamurthi, Rita Tohme, et al.
American Journal of Translational Research|April 23, 2015
Combined micro CT and histopathology for evaluation of skeletal metastasis in live animalsChristopher P Geffre, Erika Pond, Gerald D Pond, et al.
Oncogene|December 17, 2002
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cellsMei Huang, Jay F Dorsey, P K Epling-Burnette, et al.
Blood|July 13, 2014
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphomaPaul M Barr, Thomas P Miller, Jonathan W Friedberg, et al.
Pageof 3